Risk Factors for Linezolid Resistance in Staphylococcus Aureus

The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents

NCT00811980 ·Status: COMPLETED

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

NCT01561469 ·Status: COMPLETED

Virulence of Staphylococcus Lugdunensis in Severe Infections

NCT02026895 ·Status: COMPLETED ·Phase: NA

Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections

NCT03510351 ·Status: COMPLETED

Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia

NCT01819935 ·Status: COMPLETED

Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections

NCT00948142 ·Status: COMPLETED ·Phase: PHASE2

Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis

NCT03967210 ·Status: COMPLETED

Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia

NCT01356472 ·Status: UNKNOWN ·Phase: PHASE4

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

NCT01597973 ·Status: COMPLETED ·Phase: PHASE3

Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae

NCT04489459 ·Status: UNKNOWN ·Phase: PHASE4

Detection of Clindamycin Resistance Antibiotic Genes Among Staphylococcus Isolates by Using Real Time PCR

NCT04933019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Epidemiology of Klebsiella Pneumoniae in China

NCT03598543 ·Status: UNKNOWN

Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.

NCT04337840 ·Status: UNKNOWN

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

NCT01792804 ·Status: COMPLETED ·Phase: PHASE3

Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia

NCT07186894 ·Status: ACTIVE_NOT_RECRUITING

Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.

NCT01875263 ·Status: TERMINATED ·Phase: PHASE3

Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)

NCT00235690 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

NCT01701219 ·Status: COMPLETED ·Phase: PHASE4

Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia

NCT03248063 ·Status: COMPLETED ·Phase: NA

A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects

NCT02439359 ·Status: COMPLETED ·Phase: PHASE1

Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections

NCT06126263 ·Status: ACTIVE_NOT_RECRUITING

Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

NCT00572559 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia

NCT01805284 ·Status: COMPLETED ·Phase: PHASE4

Antibiotic Prophylaxis in Rhinoplasty

NCT04194216 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection

NCT02482961 ·Status: COMPLETED